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 Epithelial and Stromal Cells of Bovine Endometrium
Have Roles in Innate Immunity and Initiate
Inflammatory Responses to Bacterial Lipopeptides In
Vitro via Toll-Like Receptors TLR2, TLR1, and TLR6
Matthew L. Turner, James G. Cronin, Gareth D. Healey, and Iain Martin Sheldon
Institute of Life Science, School of Medicine, Swansea University, Singleton Park, Swansea SA2 8PP,
United Kingdom
Bacteria often infect the endometriumof cattle to cause endometritis, uterine disease, and infertility.
Lipopeptides are commonly foundamongbacteria andaredetectedby theToll-like receptor (TLR) cell
surface receptor TLR2 on immune cells. Heterodimers of TLR2 with TLR1 or TLR6 activate MAPK and
nuclear factor-B intracellular signaling pathways to stimulate inflammatory responses. In the endo-
metrium, epithelial and stromal cells are the first to encounter invading bacteria, so the present study
exploredwhether endometrial cells can alsomount inflammatory responses to bacterial lipopeptides
via TLRs. The supernatants of pure populations of primary bovine endometrial epithelial and stromal
cells accumulated the cytokine IL-6 and the chemokine IL-8 in response to triacylated or diacylated
bacterial lipopeptides. The accumulation of IL-6 and IL-8 in response to triacylated lipopeptides was
reduced by small interfering RNA targeting TLR2 or TLR1 but not TLR6, whereas cellular responses to
diacylated lipopeptide were reduced by small interfering RNA targeting TLR2, TLR1, or TLR6. Both lipo-
peptides induced rapid phosphorylation of ERK1/2, p38, and nuclear factor-B in endometrial cells, and
inhibitorsofERK1/2orp38limitedtheaccumulationofIL-6.Theovariansteroidsestradiolandprogesterone
had little impact on inflammatory responses to lipopeptides. The endometrial epithelial and stromal cell
responses to lipopeptides via TLR2, TLR1, andTLR6provide amechanism linking awide rangeof bacterial
infections to inflammation of the endometrium. (Endocrinology 155: 1453–1465, 2014)
The endometrium lining the uterus of mammals is ofteninfectedbyGram-negativeandGram-positivebacteria
ascending through the cervix, around the time of coitus or
parturition (1, 2). Postpartum bacterial infections of the
uterus are particularly common causes of disease in dairy
cows, whereas sexually transmitted infections often cause
infertility in beef breeds ofBos taurus andBos indicus (1).
Postpartum uterine disease is important because it affects
40%ofdairy cows, compromising animalwelfare, caus-
ing infertility, and diminishing the production of food for
human consumption. The combined cost for treatment of
postpartum uterine disease, lost milk production, and re-
placement of infertile animals is about $2 billion per an-
num for the combined North American and European
Union dairy industries (2). Escherichia coli is the most
commonGram-negative pathogen isolated from the post-
partum uterus of cattle, and well-established mechanisms
link endometritis to the action of the lipopolysaccharide
(LPS) cell wall component of Gram-negative bacteria (1,
3). The Gram-positive bacteria Trueperella pyogenes, Fu-
sobacterium necrophorum, Bacteroides, and Prevotella
species are also often isolated from the diseased endome-
trium postpartum (4). Sexually transmitted infections
commonly involve Trichomonas fetus,Mycoplasma spe-
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cies, and Campylobacter fetus. However, apart from
Gram-negative bacteria, it is not clear how bacteria are
detected in the endometrium orwhethermicrobial factors
other than LPS stimulate endometrial cellular responses.
Innate immunity is an ancient systemof cellular defense
based on pattern recognition receptors that bind patho-
gen-associated molecular patterns (PAMPs), which are
found in prokaryotes but not eukaryotes (5–7). The first
functional mammalian pattern recognition receptor to be
identified was Toll-like receptor (TLR) 4 on murine mac-
rophages, which binds LPS (8). Gram-positive bacteria do
not posses LPS but all bacteria, including Gram-positive
bacteria and Mycoplasma, express lipopeptides (9). Tri-
acylated lipopeptides are the most common in Gram-neg-
ative bacteria andbindTLR2,whichheterodimerizeswith
TLR1 in mice, whereas diacylated lipopeptides are found
inGram-positivebacteria orMycoplasmaandbindTLR2/
TLR6 heterodimers (10, 11). Synthetic triacylated and di-
acylated lipopeptides are used to examine TLR2 function
because preparations of native bacterial lipopeptides are
often contaminated with ligands for other TLRs, such as
LPS (12–14). In murine or human hematopoietic cells,
engagement of TLR2/TLR1 and TLR2/TLR6 het-
erodimers by triacylated and diacylated lipopeptides, re-
spectively, activates MAPK and nuclear factor of  light
polypeptide gene enhancer in B-cells (NFB) intracellular
signaling pathways. Phosphorylation of p38 (also known
as MAPK14) or ERK1/2 (also known as MAPK3/1), or
phosphorylation of p65 NFB leads to gene transcription
and secretion of cytokines such as IL-1, IL-6, and TNF,
and chemokines such as IL-8 (5, 6).
In cattle, mRNA transcripts for cytokines IL1B and
IL6, and the chemokine IL8 are more abundant in the
endometrium of diseased than normal animals (15, 16).
Epithelial and stromal cells are the first to encounter bac-
teria invading the endometrium, and these cells express
TLR4mRNAandsecrete IL-6and IL-8 in response toLPS,
via TLR4-dependent activation of p38, ERK1/2, and
NFB signaling pathways (17, 18). However, whereas en-
dometrial cells express TLR2, TLR1, and TLR6 mRNA,
there is little evidence in any species about whether pri-
mary endometrial cells detect bacterial lipopeptides (2,
19). The genomic conservation for each of the TLR2,
TLR1, and TLR6 genes is 96% among Bos taurus and
Bos indicus, but conservation between B. taurus and
Homo sapiens is 84% to 88% and between B. taurus and
Musmusculus is only 75%to78%.There are also species-
dependent variations in responses associated with innate
immunity (20). Thus, to explore whether TLR2 is impor-
tant in the bovine endometrium, it is essential to examine
tissues from the target species.
The present study tested the hypothesis that bovine en-
dometrial epithelial and stromal cells mount inflamma-
tory responses to bacterial lipopeptides via TLR2, TLR1,
and TLR6 pathways. Bovine endometrial cells produced
IL-6 and IL-8 in response to triacylated lipopeptide, and
the response was blunted using small interfering RNA
(siRNA) targeting TLR2 or TLR1. There were similar cel-
lular responses to diacylated lipopeptide, and siRNA tar-
geting TLR2, TLR1, or TLR6 reduced the accumulation
of IL-6 and IL-8. Phosphorylation of p38, ERK1/2, and
NFB in response to lipopeptides provided further evi-
dence of TLR2 function. Furthermore, cellular responses
to lipoproteinswere reducedby inhibitors targetingp38or
ERK1/2. In summary, endometrial cells have roles in in-
nate immunity to sense and respond to triacylated and
diacylated lipopeptides, which provides a mechanism
linking endometritis to a wide range of bacteria.
Materials and Methods
Isolation and culture of endometrial cells
Uteri with no gross evidence of genital disease or microbial
infection and peripheral blood samples were collected from
2.2  0.1-year-old postpubertal mixed-breed beef cattle within
15 minutes of slaughter at a local slaughterhouse; the studies
used80 animals. Postpartum cattle were not used because ex-
periments would be confounded by the usual ubiquitous bacte-
rial contamination of the uterus and disruption of the epithelium
typical of the puerperal endometrium (2, 15, 16, 21). The stage
of the reproductive cycle was determined by examination of
ovarian morphology and vasculature, as described previously
(22); uteri at ovarian stage I (days 1–4 of the estrous cycle) were
selected for endometrial cell culture because peripheral plasma
progesterone concentrations are basal, similar to those of post-
partumcows.Theuteriwerekept on ice for1houruntil further
processing at the laboratory.
Endometrial tissue was dissected and processed as described
previously (17, 18). In brief, tissue was digested in 25 mL of
sterile digestive solution, made by dissolving 50 mg of trypsin
(Sigma-Aldrich), 50 mg of collagenase II (Sigma-Aldrich), 100
mg of BSA (Sigma-Aldrich), and 10 mg of DNase I (Sigma-Al-
drich) in 100mL ofHanks’ balanced salt solution (Sigma). After
a 1-hour incubation in a shaking water bath at 37°C, the cell
suspensionwas filtered through a 40-mmesh (Fisher Scientific)
to remove undigested material. The filtrate was resuspended in
washing medium, composed of Hanks’ balanced salt solution
with 10% heat-inactivated fetal bovine serum (FBS) (Biosera).
The suspension was centrifuged at 700  g for 7 minutes, and
after 2 further washes in washing medium, the cells were re-
suspended in endometrial cell culture medium (RPMI 1640
medium, 10% FBS, 50 IU/mL of penicillin, 50 g/mL of strep-
tomycin, and 2.5 g/mL of amphotericin B; all from Sigma-
Aldrich). All experiments used the same batch of FBS, which
during previous batch testing yielded the lowest concentrations
of cytokines andchemokines in supernatants of endometrial cells
and macrophages cultured in endometrial cell culture medium
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(10 batches from 4 companies tested). The cells were cultured in
75-cm2 flasks (Greiner Bio-One) for 18 hours to allow selective
attachment of stromal cells, with the remaining epithelial cell
suspension transferred to a new flask. The cells were incubated
at 37°C in a humidified atmosphere of air with 5% CO2, and
endometrial cell culture medium was changed every 48 hours.
Epithelial and stromal cell populationswere distinguishedby cell
morphology, and the absence of immune cell contaminationwas
confirmed by the absence of CD45, as described previously (17,
23). The epithelial or stromal cells were resuspended and plated
at 1.5105 cells/mL in 1mL for 24-well plates (TPP) to examine
cytokine or chemokine responses, in 2 mL for 12-well plates for
collectionof cells for immunoblotting, and in 6-well plates to test
the role of TLRs using siRNA, as described below.
To examine endometrial cell purity, endometrial epithelial
cells, stromal cells, and whole blood samples were suspended in
BSA stain buffer (BD Biosciences) at 1  107 cells/mL for fluo-
rescence-activated cell sorting (FACS) analysis. For surface stain-
ing, RPE-conjugated mouse anti-CD45 (MA1–81458; Thermo
Scientific) hematopoietic cellmarkeror the isotype control,RPE-
conjugated anti-mouse IgG1 (PA5–33180; Thermo Scientific)
was added to 100-L aliquots of the purified cells and incubated
on ice for 30 minutes in the dark. After staining, cells were
washed twice by centrifuging at 520 g for 7minutes, removing
the supernatant, and resuspending in BSA stain buffer. For in-
tracellular staining, 100-L aliquots of the purified cell popu-
lations, suspended at 1 107 cells/mL in BSA stain buffer, were
fixed with BD Cytofix (BD Biosciences) for 30 minutes on ice,
washed twice as above, and then permeabilizedwith PermBuffer
III (BD Biosciences) for a further 30 minutes on ice. After per-
meabilization, cells were washed twice and stained with allo-
phycocyanin-conjugated mouse anti–pan-cytokeratin (ab106166;
Abcam) as a marker of epithelia, fluorescein isothiocyanate–
conjugated mouse anti-vimentin (BM5501F; Acris Antibodies)
as a mesenchymal cell marker, or the isotype controls, allophy-
cocyanin-conjugated anti-mouse IgG1 (406609; BioLegend Inc)
or fluorescein isothiocyanate–conjugated anti-mouse IgG2a
(407105; BioLegend Inc), respectively, for 30 minutes on ice, in
the dark. Cells were then washed twice, as above, and resus-
pended in BSA stain buffer for analysis. Analysis was performed
on a BDFACSAria III cell sorter instrument using BDFACSDiva
v6.1 software (BD Biosciences). At least 1  104 cells were ac-
quired per sample, and dead cells were excluded by selective
scatter gating.
Endometrial cell responses to PAMPs
To evaluate responses to PAMPs, endometrial cells were
treated with ultrapure preparations of the triacylated lipo-
peptide N-palmitoyl-S-[2,3-bis(palmitoyloxy)-(2RS)-propyl]-
[R]-cysteinyl-[S]-seryl-[S]-lysyl-[S]-lysyl-[S]-lysyl-[S]-lysine (PAM,
Pam3CSK4), diacylated lipopeptide [S-(2,3-bispalmitoyloxy-
propyl) Cys-Gly-Asp-Pro-Lys-His-Pro-Lys-Ser-Phe (FSL-1,
Pam2CGDPKHPKSF), and LPS from E. coli 0111:B4 as a pos-
itive control (all from InvivoGen). Epithelial or stromal cells
80% confluent in 24-well culture plates were treated with en-
dometrial cell culture medium containing vehicle or 10-fold in-
creasing concentrations from0.1 to 1000ng/mLPAM,FSL-1, or
LPS. These concentrations span the range recommended by the
manufacturer and reflect concentrations of LPSmeasured in dis-
eased cattle (14 days postpartum: uterine fluid, 18–262 g/mL
LPS; and peripheral plasma, 0–0.6 ng/mL LPS) (24). After 24
hours, cell-free culture supernatants were collected and stored at
20°C for analysis of inflammatory mediators by ELISA. For
each PAMP, experiments were repeated on 3 independent occa-
sions, with treatments applied to duplicate replicate wells.
To evaluate the role of TLRs in cellular responses to lipo-
peptides, siRNA was used to target TLR2, TLR1, and TLR6.
The siRNAs were designed using siDESIGN Center (www.
thermoscientificbio.com/design-center/) and duplex sequences
were as follows: TLR2, sense GGACAGAAUUAGACAC-
CUAUU and antisense UAGGUGUCUAAUUCUGUCCUU
(Genbank accession number NM_174197.2); TLR1, sense
UGAUGAAAGUGAAGGAAAUUU and antisense AUUUCC-
UUCACUUUCAUCAUU (NM_001046504.1); and TLR6, sense
CAGAAUAGUUUCACAGAUAUU and antisense UAUCUGU-
GAAACUAUUCUGUU (NM_001001159.1). The RNAiMAX-
RNAi duplex complexes were formed by addition of 50 pmol of
target siRNA or ON-TARGETplus nontargeting siRNA no. 1
(scramble; Dharmacon) to 500 L of Opti-MEM I Reduced Se-
rum Medium without antibiotics (Invitrogen) to each well of a
6-well culture plate, with 7.5 L of Lipofectamine RNAiMAX
(Invitrogen) added to the siRNA duplex and control wells and
incubated for 20minutes at room temperature.Growing2105
epithelial cells or 1.5  105 stromal cells were seeded into each
well in 2.5 mL of complete RPMI 1640 growth media without
antibiotics to yield approximately 50% confluence. After 24
hours, the cells were washed with Dulbecco PBS and lysed using
Buffer RLT for analysis of TLR mRNA by quantitative PCR.
Alternatively, cells were treated with control endometrial cell
culture medium or medium containing 100 ng/mL PAM or
FSL-1, because these concentrations stimulated cellular respons-
es; after 24 hours, culture supernatantswere collected and stored
at20°C for analysis of inflammatorymediators by ELISA, and
cell survival was evaluated by the 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) assay (see below). The
experiments were repeated on 3 independent occasions for each
TLR.
Todeterminewhether intracellularMAPKorNFB signaling
pathways were activated by lipopeptides, epithelial or stromal
cells in 12-well culture plates were cultured in Opti-MEM I Re-
duced SerumMediumormediumcontaining100ng/mLPAMor
FSL-1. Cells were collected after 0, 5, 10, 15, 20, and 25minutes
of treatment, washed with Dulbecco PBS, lysed by addition of
200 L of Phosphosafe Extraction Reagent (Merck), and stored
at80°C for analysis by immunoblotting.The experimentswere
repeated on 3 independent occasions.
To further evaluate the role of intracellular signaling path-
ways in the response to lipopeptides, inhibitors targetingMAPK
were tested using previously validated concentrations for bovine
cells, although inhibitors of NFB were not used because they
cause cell death (18). Epithelial or stromal cells cultured in 24-
well plates were treated with an inhibitor of ERK1/2 activation
(10 MERK activation inhibitor peptide I, catalog no. 328000;
Merck Chemicals) or an inhibitor of p38 (10 M InSolution,
SB203580; Merck Chemicals) for 30 minutes before and during
treatment with endometrial cell culture medium containing 100
ng/mL PAM or FSL-1; the controls for each experiment were an
equivalent volume of medium and vehicle, and an equivalent
volume of medium and each inhibitor. Inhibitors were selected
on the basis of evidence of selectivity, suppressionof endometrial
cell inflammatory responses to LPS, and preliminary experi-
ments showing reduced phosphorylation ofMAPK (Supplemen-
doi: 10.1210/en.2013-1822 endo.endojournals.org 1455
The Endocrine Society. Downloaded from press.endocrine.org by [${individualUser.displayName}] on 29 March 2015. at 13:37 For personal use only. No other uses without permission. . All rights reserved.
tal Figure 1 published on The Endocrine Society’s Journals On-
line web site at http://end.endojournals.org) (18, 25, 26). After 6
hours, cell supernatants were collected and stored at20°C for
analysis of IL-6 by ELISA, and cell survival was evaluated by the
MTT assay. The experiments were repeated on 3 independent
occasions, with treatments applied to duplicate replicate wells.
To evaluate the impact of ovarian steroids on cellular re-
sponses to lipopeptides, endometrial cells were treatedwith con-
centrations of estradiol or progesterone that reflect the concen-
tration in peripheral plasma during estrus or the luteal phase,
respectively. Epithelial or stromal cells in 24-well plates were
cultured inRPMI1640without phenol red (Sigma-Aldrich) con-
taining 10% charcoal-stripped FBS, with 50 IU/mL of penicillin,
50 g/mL of streptomycin, and 2.5 g/mL amphotericin B and
treated with 3 pg/mL estradiol (Sigma-Aldrich), 5 ng/mL pro-
gesterone (Sigma-Aldrich), a combination of estradiol and pro-
gesterone, or 5 ng/mL dexamethasone (Sigma-Aldrich) as a pos-
itive control. After 24 hours, the cells were treated with vehicle
or 100 ng/mL PAMor FSL-1 for a further 24 hours, and then the
cell supernatantswere collected and stored at20°C for analysis
of IL-6 by ELISA.
ELISA
Concentrations of IL-1, IL-6, IL-8, and TNF in cell culture
supernatants were measured by ELISA according to the manu-
facturer’s instructions (Bovine IL-1 Screening Set ESS0027 and
Bovine IL-6 Screening Set ESS0029 [Thermo Scientific] and Bo-
vine TNF DuoSet DY2279 and Human CXCL8/IL-8 DuoSet
DY208 [R&D Systems Europe Ltd]). The human IL-8 assay has
previously been shown to cross-react with bovine IL-8 (27). The
inter-assay and intra-assay coefficients of variation were all
10%; the limits of detection were 12.5 pg/mL for IL-1, 75.0
pg/mL for IL-6, 83.2 pg/mL for TNF, and 5.7 pg/mL for IL-8.
Immunoblotting
Proteins were quantified using the DC Assay (Bio-Rad) and
separated (10 g/lane) using 12% (vol/vol) SDS-PAGE with
prestainedmolecularweightmarkers (Bio-Rad) in parallel lanes.
After electrophoresis, proteins were transferred to a polyvi-
nylidene difluoride membrane (Bio-Rad); nonspecific sites were
blocked using a solution of 5% (wt/vol) BSA (Sigma-Aldrich) in
Tris-buffered saline and 0.1% Tween 20 (TBS/T) overnight at
4°C with gentle agitation. Membranes were probed with anti-
bodies targeting total and phosphorylated forms of ERK1/2
(anti-ERK1/2 [AB17942; [Abcam] and anti-MAPK activated
diphosphorylated ERK1/2 [M8159; Sigma-Aldrich]), p38
(MAPK p38/MAPK14 [AP03041SU-N; Acris antibodies,
2B Scientific] and MAPK p38/MAPK14pThr180/pTyr182
[AP05898PU-N, Acris antibodies, 2B Scientific]), and NFB
(NFB p65 [4764S; New England Biolabs] and phospho NFB
p65(Ser536) [3033L;NewEngland Biolabs]), with protein load-
ing confirmed using antibodies against -tubulin (bovine -tu-
bulin, A11126; Invitrogen) or -actin (bovine anti- actin,
ab8226; Abcam); the antibodies are further detailed in Supple-
mental Table 1 and were selected on the basis of recognition of
immunoreactive proteins of appropriate molecular weight and
previous publications (18, 28, 29). Membranes were incubated
with primary antibodies diluted in 5% (wt/vol) BSA inTBS/T for
2 hourswith gentle agitation.After incubation,membraneswere
washed 4 times for 5 minutes in TBS/T. Membranes were then
incubated with secondary horseradish peroxidase–conjugated
antibody in 5% (wt/vol) BSA in TBS/T for 1.5 hours andwashed
4 times for 5 minutes in TBS/T. Immunoreactive proteins were
visualized using enhanced chemiluminescence (Western C; Bio-
Rad). The average peak densities of unsaturated bands were an-
alyzed using Quantity One software (Bio-Rad) with the band
intensities for each phosphorylated protein normalized against
the bands for their respective total protein, and data are pre-
sented relative to cells at time 0.
MTT assay
The number of cells per well at the end of treatment was
evaluated by MTT assays. After removal of cell culture super-
natants, cells were incubated in 250 L of 0.5 mg/mL MTT
(Sigma-Aldrich) for 1 hour at 37°C, with 5% CO2 in air, in a
humidified incubator. Then the medium was removed, and the
cells were washed with Dulbecco PBS before lysis using dimeth-
ylsulfoxide, with OD measured at 570 nm using a microplate
reader (POLARstar Omega; BMG Labtech). In addition, in pre-
liminary studies, the number of cells per well at the start of treat-
ment did not differ significantly (all within 9%).
Quantitative PCR
At the end of each experiment, endometrial cellswerewashed
with1mLofPBS, andRNAwas extractedusing anRNeasyMini
Kit andautomatedQIAcube system (QIAGEN), according to the
manufacturer’s instructions. Extracted RNA was quantified us-
ing aNanoDropND1000 spectrophotometer (Labtech), and the
purity of each samplewas determined by the ratioA260/A280. An
A260/A280 ratio of between 1.8 and 2.1 was considered suitable
for further investigation. For cDNA synthesis, 1g of total RNA
was added to a genomic DNA elimination reaction, followed by
reverse transcription to cDNA (QuantiTect Reverse Transcrip-
tion Kit; QIAGEN), according to the manufacturer’s instruc-
tions. Quantitative PCR was performed according to previ-
ously published guidelines (30) using QuantiFast SYBR Green
(QIAGEN) and the iQ5 RT-PCR detection system (Bio-Rad)
with software version 2.1.97.1001. Each sample was assayed in
triplicate using intron-spanningprimers designedwith theonline
software NCBI/Primer-Basic Local Alignment Search Tool (Na-
tional Center for Biotechnology Information). Target-specific
primers generated PCR products of up to 200 bp (Supplemental
Table 2). The ACTB gene, which was invariant across the treat-
ments used, was chosen as the reference gene for normalization,
and the relative quantification method was used to quantify tar-
get gene mRNA within samples (31). To generate standard
curves, total RNA extracted from stromal cells that had been
treatedwith 100ng/mLLPS for 24hourswas reverse transcribed
to cDNA, as described previously. Ten-fold serial dilutions of
this reference cDNA were prepared (undiluted to 1  103) in
RNase-free water. PCR conditions consisted of 25-L reactions
containing 2 L of cDNA, and thermal cycling parameters were
1 cycle of 95°C for 5 minutes, followed by 40 cycles of 95°C for
30 seconds and 60°C for 60 seconds; a melt curve was subse-
quently generated to confirm the specificity and identity of PCR
products. For each sample, target and reference gene mRNA
abundancewas determined from the appropriate standard curve
(quantification cycle, Cq). Changes in mRNA abundance be-
tween samples were then determined from the ratio of the target
gene Cq to the reference gene Cq.
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Statistical analysis
Data are presented as the arithmetic means and SEM. Statis-
tical analyseswereperformedusingSPSS16.0 (SPSS Inc)with the
animal as the designated statistical unit, and a value of P  .05
was considered statistically significant. Treatments were com-
paredusingANOVAwith theDunnett post hoc test for normally
distributed data or by theMann-Whitney test for nonparametric
data. Because we were aware of between-animal biological vari-
ation for primary cell cultures, for analysis of the impact of
siRNA or inhibitors, the concentrations of inflammatory medi-
ators were expressed for each animal as a percentage of the re-
sponse to treatment with each PAMP.
Results
Endometrial cells respond to PAMPs
Endometrial cells were not contaminated with hema-
topoietic cells as determined by FACS analysis for CD45
expression (Figure 1, A–C). Epithelial but few stromal
cells expressed the epithelialmarker cytokeratin (Figure 1,
D–F), andmore stromal than epithelial cells expressed the
mesenchymal cell marker vimentin (Figure 1, G–I).
The supernatants of endometrial epithelial or stromal
cells accumulated more IL-6 and IL-8 in response to 24
hours of treatment with PAM or FSL-1 compared with
those for the vehicle control (Figure 1, J–M). The concen-
tration-dependent accumulation of IL-6 and IL-8 after
treatmentwith PAMor FSL-1was similar inmagnitude to
that of cells treated with the prototypical PAMP, LPS.
However, the concentrations of IL-1 and TNF were
below the limits of detectionof the assays for PAM,FSL-1,
and LPS. Cell survival and variations in cell density be-
tween culture wells were evaluated by the MTT assay,
which was not significantly affected by treatment with
PAM (97.1  4.2% [epithelium] and 105.5  3.0%
[stroma] of vehicle), FSL-1 (106.1  10.9% [epithelium]
and 115.2  3.8% [stroma] of vehicle), or LPS (111.4 
10.9% [epithelium] and 125.6  12.2% [stroma] of ve-
hicle). Because IL-6 and IL-8 responses were detectable at
concentrations of 100 ng/mL PAM or 100 ng/mL FSL-1,
these concentrations of lipopeptides were used for subse-
quent experiments.
Endometrial cells respond to lipopeptides via TLRs
To evaluate the role of TLRs in responses to lipopep-
tides, endometrial epithelial and stromal cells were trans-
fected with siRNA targeting TLR2, TLR1, or TLR6,
which reduced mRNA expression for TLR2 (Figure 2, A
and B), TLR1 (Figure 3, A and B), and TLR6 (Figure 4, A
and B), compared with that for cells transfected with
scramble siRNA.Noneof the siRNAsignificantly affected
the basal accumulation of IL-6 or IL-8 from cells cultured
in controlmedium (Supplemental Figure 2) or cell survival
or variation in cell density between culture wells (MTT
assay ODs all within 14% of that for cells in control
medium). The supernatants of epithelial cells treated with
PAMorFSL-1 for 24hours had increased accumulationof
IL-6 (control, 100.1  40.8 pg/mL; PAM, 190.6  59.0
pg/mL; and FSL-1, 149.3  48.1 pg/mL; n  9, P  .05)
and IL-8 (control, 0.4  0.3 pg/mL; PAM, 10.3  2.4
pg/mL; and FSL-1, 26.6 3.5 pg/mL; n 9,P .05), and
stromal cells treated with PAM or FSL-1 had increased
accumulation of IL-6 (control, 27.8  9.9 pg/mL; PAM,
1382.9 380.0 pg/mL; and FSL-1, 148.6 27.4 pg/mL;
n 9, P .05) and IL-8 (control, 4.3 2.5 pg/mL; PAM,
31.6 11.3 pg/mL; and FSL-1, 20.2 3.8 pg/mL; n 9,
P  .05). The concentrations of inflammatory mediators
are expressed as a percentage of the response to PAM or
FSL-1 to examine the impact of the targeting siRNA. The
effect of siRNA targeting TLR2 on endometrial cellular
responses to lipopeptides was examined first because li-
popeptides are bound by TLR2 irrespective of whether
they are triacylated or diacylated (10). Indeed, siRNA tar-
getingTLR2 reduced the accumulation of IL-6 and IL-8 in
the supernatants of epithelial cells treated with PAM (Fig-
ure 2, C andE) or FSL-1 (Figure 2,D and F) and in stromal
cells treatedwith PAM(Figure 2,Gand I) or FSL-1 (Figure
2,Hand J), comparedwith cells transfectedwith scramble
siRNA.Theuseof siRNAtargetingTLR1also reduced the
accumulation of IL-6 and IL-8 in the supernatants of ep-
ithelial cells treatedwithPAM(Figure3,CandE)orFSL-1
(Figure 3, D and F) and stromal cells treated with PAM
(Figure 3, G and I) or FSL-1 (Figure 3, H and J). However,
siRNA targeting TLR6 reduced the accumulation of IL-6
and IL-8 in the supernatants of epithelial cells treatedwith
FSL-1 (Figure 4, D and F) but not with PAM (Figure 4, C
and E). Similarly, siRNA targeting TLR6 reduced the ac-
cumulationof IL-6 and IL-8 in the supernatants of stromal
cells treated with FSL-1 (Figure 4, H and J) but not with
PAM (Figure 4, G and I).
Activation of MAPK and NFB in response to
lipopeptides
Activation of MAPK and NFB signaling was examined
to seek further evidence for functional TLR responses to li-
popeptides in endometrial cells. Epithelial cells had more
phosphorylated p38 after treatment with PAM and more
phosphorylated p38 and phosphorylated ERK1 after treat-
ment with FSL-1 (Figure 5A). Stromal cells had increased
abundanceofphosphorylatedERK2andp38after treatment
withPAMorFSL-1(Figure5B).Epithelialcellshadincreased
abundance of phosphorylated p65 NFB after treatment
with PAMor FSL-1 (Figure 6A). Stromal cells had increased
abundance of phosphorylated p65 NFB after treatment
with PAM but not FSL-1 (Figure 6B).
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Figure 1. Endometrial cell purity and response to PAMPs. Purified populations of epithelial or stromal cells or whole blood samples were stained
for the cell surface hematopoietic cell marker CD45 or the intracellular epithelial and mesenchymal markers cytokeratin and vimentin, respectively.
Flow cytometry histograms present data in blue for cells stained with CD45 (A, B, and C), cytokeratin (D, E, and F), or vimentin (G, H, and I), and in
red for the cognate isotype control. Histograms depict a representative sample from 1 animal using 10,000 cells for each analysis. Values in boxes
are the mean percent staining compared with that for the relevant isotype control  SEM, for 3 independent animals. Epithelial (J and K) and
stromal cells (L and M) isolated from bovine endometrium were cultured for 24 hours in medium containing vehicle (V) or 0.1, 1, 10, 100, to 1000
ng/mL PAM, FSL-1, or LPS. Supernatants were harvested to measure the accumulation of IL-6 (J and L) and IL-8 (K and M) by ELISA. Data are
presented as mean 	 SEM and represent 3 independent experiments for each PAMP. Values differ significantly from those for vehicle when data
were analyzed by ANOVA using the Dunnett pairwise multiple comparison t test: *, P  .05; **, P  .01
.
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Figure 2. Attenuation of endometrial cell responses to lipopeptide
PAMPs by siRNA targeting TLR2. Epithelial (A and C–F) and stromal
cells (B and G–J) isolated from bovine endometrium were treated
with vehicle (V), nontargeting scramble siRNA (S), or siRNA
targeting TLR2 (siTLR2) before treatment with control medium or
medium containing 100 ng/mL PAM or 100 ng/mL FSL-1. A and B,
Cells in control medium were collected, and the expression of TLR2
mRNA was quantified by PCR relative to ACTB expression. Data are
presented as mean 	 SEM fold of mRNA expression in cells treated
with scramble siRNA from 3 independent experiments. Values differ
from those for scramble and vehicle when analyzed by the Mann-
Whitney U test: *, P  .05. C–J, Culture supernatants were
harvested to measure the accumulation of IL-6 and IL-8 by ELISA,
and results are expressed as the percentage of treatment with each
PAMP from independent experiments (PAM, n  4; FSL-1, n  3).
Data are presented as mean 	 SEM, and values differ significantly
from those for scramble siRNA when analyzed by ANOVA using the
Dunnett pairwise multiple comparison t test: *, P  .05.
Figure 3. Attenuation of endometrial cell responses to lipopeptide
PAMPs by siRNA targeting TLR1. Epithelial (A and C–F) and stromal
cells (B and G–J) isolated from bovine endometrium were treated
with vehicle (V), nontargeting scramble siRNA (S), or siRNA
targeting TLR1 (siTLR1) before treatment with control medium or
medium containing 100 ng/mL PAM or 100 ng/mL FSL-1. A and B,
Cells in control medium were collected, and the expression of TLR1
mRNA was quantified by PCR relative to ACTB expression. Data are
presented as mean  SEM fold of mRNA expression in cells treated
with scramble siRNA from 3 independent experiments. Values differ
from those for scramble and vehicle when analyzed by the Mann-
Whitney U test: *, P  .05. C–J, Culture supernatants were
harvested to measure the accumulation of IL-6 and IL-8 by ELISA,
and results are expressed as the percentage of treatment with each
PAMP from independent experiments (PAM, n  4; FSL-1, n  4).
Data are presented as mean 	 SEM, and values differ significantly
from those for scramble siRNA, when analyzed by ANOVA using the
Dunnett pairwise multiple comparison t test: *, P  .05.
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MAPK inhibitors limit cellular response to
lipopeptides
The accumulation of IL-6 in the supernatant of endo-
metrial stromal cells was used as an exemplar to further
evaluate the role of MAPK signaling pathways in the re-
sponse to lipopeptides. Treatment with PAMor FSL-1 for
6 hours increased the accumulation of IL-6 in superna-
tants of epithelial cells (control, 27.9 5.3 pg/mL; PAM,
82.6  9.5 pg/mL; and FSL-1, 76.8  9.4 pg/mL; n  6,
P  .05) and stromal cells (control, 16.8  3.7 pg/mL;
Figure 4. Attenuation of endometrial cell responses to lipopeptide
PAMPs by siRNA targeting TLR6. Epithelial (A and C–F) and stromal cells (B
and G–J) isolated from bovine endometrium were treated with vehicle (V),
nontargeting scramble siRNA (S), or siRNA targeting TLR6 (siTLR6) before
treatment with control medium or medium containing 100 ng/mL PAM or
100 ng/mL FSL-1. A and B, Cells in control medium were collected, and
the expression of TLR6mRNA was quantified by PCR relative to ACTB
expression. Data are presented as means SEM fold of mRNA expression
in cells treated with scramble siRNA from 3 independent experiments.
Values differ from those for scramble and vehicle when analyzed by the
Mann-Whitney U test: *, P .05. C–J, Culture supernatants were
harvested to measure the accumulation of IL-6 and IL-8 by ELISA, and
results are expressed as the percentage of treatment with each PAMP
from independent experiments (PAM, n 4; FSL-1, n 4). Data are
presented as mean	 SEM, and values differ significantly from those for
scramble siRNA when analyzed by ANOVA using the Dunnett pairwise
multiple comparison t test: *, P .05; ND, below limits of detection.
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Figure 5. Activation of MAPK in endometrial cells treated with
lipopeptide PAMPs. Endometrial epithelial cells (A) and stromal cells (B)
were collected 0, 5, 10, 15, 20, or 25 minutes after treatment with
100 ng/mL PAM or 100 ng/mL FSL-1. The protein from the cells was
analyzed by SDS-PAGE and immunoblotted with antibodies against
total and phosphorylated forms of p38 (t-p38 and p-p38) and ERK1/2
(tERK1/2 and pERK1/2; , tERK2; f, pERK2), and -tubulin as visual
confirmation of the precision of protein loading and transfer. The
image for each cell type is representative of 3 independent
experiments for PAM (left panel) or FSL-1 (right panel), and the
histograms represent the mean  SEM of densitometric analysis of the
ratio of phosphorylated p-p38 to t-p38, pERK1 to tERK1 or pERK2 to
tERK2, expressed as fold activation compared with time 0. Values
differ from time 0 when data were analyzed by ANOVA, using the
Dunnett pairwise multiple comparison t test: *, P  .05.
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PAM, 503.3  99.1 pg/mL; and FSL-1, 502.3  180.8
pg/mL; n  6, P  .05). Inhibitors targeting ERK1/2 or
p38 reduced the accumulation of IL-6 in supernatants of
epithelial (Figure 7, A and B) or stromal cells (Figure 7, B
and D) treated with PAM or FSL-1. Cell survival was not
significantly affectedby the inhibitor forERK1/2 (118.5
11.9% [epithelium MTT assay] and 104.6  6.9%
[stroma] of vehicle) or p38 (104.6  13.5% [epithelium]
and 114.8 6.0% [stroma] of vehicle), and the inhibitors
did not significantly affect cell survival or cell density in
culture wells in the presence of PAM or FSL-1 (OD in the
range of 94.1 to 121.2% of vehicle for epithelium and
103.4 to 111.0% for stroma).
Ovarian steroids
The stage of the estrous cycle may modulate inflam-
matory responses in the endometrium (32). Therefore, the
impact of estradiol, progesterone, or a combination was
examined in cells treatedwithPAMorFSL-1.As expected,
treatment for 24 hours with PAM or FSL-1 increased the
accumulation of IL-6 in supernatants of epithelial cells
(P .001) (Figure 8A) and stromal cells (P .001) (Figure
8B) compared with control medium. However, the ovar-
ian steroidsdidnot significantly affect theaccumulationof
IL-6 in epithelial cells, although dexamethasone consid-
erably reduced the response to PAMor FSL-1 (Figure 8A).
A combination of estradiol and progesterone modestly
reduced the accumulation of IL-6 by stromal cells treated
with FSL-1 but not with PAM (Figure 8B).
Discussion
Endometrial epithelial and stromal cells encounter many
species of bacteria that infect the uterus around the time of
coitus or after parturition (1, 2, 33). The present study
examined whether these epithelial and stromal cells have
roles in the detection and response to bacterial lipopep-
tides. The supernatants of primary endometrial cells ac-
cumulated IL-6 and IL-8 in a concentration-dependent
manner when treated with triacylated and diacylated li-
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Figure 6. Activation of p65 NFB in endometrial cells treated with
lipopeptide PAMPs. Endometrial epithelial cells (A) and stromal cells (B)
were collected 0, 5, 10, 15, 20, or 25 minutes after treatment with
100 ng/mL PAM or 100 ng/mL FSL-1. The protein from the cells was
analyzed by SDS-PAGE and immunoblotted with antibodies against
total and phosphorylated forms of p65 NFB (t-p65 and p-p65) and
-actin as visual confirmation of the precision of protein loading. The
image for each cell type is representative of 3 independent
experiments for PAM (left panel) or FSL-1 (right panel), and the
histograms represent the mean 	 SEM of the densitometric analysis of
the ratio of phosphorylated to total p65 NFB, expressed as fold
activation compared with time 0. Values differ from time 0 when data
were analyzed by ANOVA, using the Dunnett pairwise multiple
comparison t test: *, P  .05.
Figure 7. Attenuation of endometrial cell responses to lipopeptides
by inhibition of MAPK. Endometrial epithelial (A and B) or stromal cells
(C and D) were treated for 30 minutes in medium containing vehicle
(V), ERK1/2 inhibitor (ERKi) (ERK activation inhibitor peptide I, 10 M)
or p38 inhibitor (p38i) (InSolution SB 203580, 10 M) and then were
cultured in the same treatment for 6 hours in control medium or
medium containing 100 ng/mL PAM (A and C) or 100 ng/mL FSL-1 (B
and D). Supernatants were harvested to measure the accumulation of
IL-6 by ELISA, and results are expressed as a percentage of treatment
with PAM (A and C) or FSL-1 (B and D). Data are presented as mean 	
SEM percentages and represent 3 independent experiments. Values
differ from those for PAMP when data were analyzed by ANOVA using
the Dunnett pairwise multiple comparison t test: *, P  .05.
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popeptides. The cellular responses to the triacylated lipo-
peptide PAM were mediated by TLR1 and TLR2. How-
ever, unlikemouse or human cells, the bovine endometrial
cell responses to the diacylated lipopeptide FSL-1 involved
TLR1, as well as TLR2 and TLR6. The functional re-
sponses to the lipopeptides were supported by evidence of
activationof intracellularMAPKandNFBsignaling, and
inhibitors targeting ERK1/2 or p38 blunted the IL-6 cel-
lular response to lipopeptides. However, ovarian steroids
had little effect on the cellular response to lipopeptides,
although dexamethasone blunted epithelial cell IL-6 ac-
cumulation. These data support the hypothesis that epi-
thelial and stromal cells have a generalized role in innate
immunity to initiate inflammatory responses to a wide
range of bacteria that infect the endometrium, by sensing
bacterial lipopeptides using TLR2 in concert with TLR1
and TLR6.
Gene transcripts for IL6 and IL8 aremore abundant in
the endometrium of cattle with uterine disease than in
normal animals (15, 16) and in endometrial explants
treated with heat-killed Gram-positive bacteria or bacte-
rial lipopeptides (34). Similarly, in vitro organ culture of
bovine endometrium with clinical isolates of Gram-neg-
ative or Gram-positive bacteria stimulated accumulation
of IL-6 and IL-8 protein (32). Previously we established
that endometrial epithelial and stromal cells respond to
pathogenic E. coli via TLR4-dependent responses to LPS
(17, 18, 35). However, it was not clear whether endome-
trial cells could detect a wider diversity of bacteria, in-
cluding Gram-positive bacteria and Mycoplasma. Lipo-
peptides constitute 1% to 3% of bacterial genomes with
roles in physiology and virulence, with triacylated lipo-
peptides predominant in Gram-negative species, whereas
mainly diacylated forms are found among Gram-positive
bacteria andMycoplasma (9). In the present study, triacy-
lated anddiacylated lipopeptides stimulated epithelial and
stromal cell secretion of IL-6 and IL-8 in a concentration-
dependentmanner,with a cellular sensitivity similar to the
response to the prototypical PAMP, LPS. Although the
synthetic lipopeptides are obviously not found in vivo,
they mimic the inflammatory responses of cells to native
bacterial lipopeptides but avoidmultiple issues associated
with contamination of native lipopeptide preparations
with ligands that bind other TLRs (14). In the present
study, the lipopeptide concentrations tested in vitro
spanned the range recommended by the manufacturer for
working with immune cells. Bacteria are highly abundant
in uterine disease, often with 1000 bacterial colonies
cultured from a uterine swab, and the LPS concentrations
reflected those measured in the uterine lumen of diseased
cattle (24). The endometrial cells had little or no hemato-
poietic cell contamination, as determined by FACS anal-
ysis forCD45.The cytokeratin expression showed that the
epithelial and stromal cellswere distinct, and, as expected,
epithelial cells were positive for cytokeratin and vimentin,
whereas most stromal cells expressed vimentin (36). The
endometrial cell cytokine and chemokine responses to
bacterial lipopeptides were typical of cells involved in in-
nate immunity across mammals (5, 6). It is not clear
whether endometrial stromal cells from other species re-
spond to lipopeptides, although PAM-stimulated rat en-
dometrial epithelial cells releaseCCL20 (37).The IL-6and
IL-8 secretion by endometrial cells in response to lipopep-
tides in vitro, in the present study, mimics the increased
expression of IL6 and IL8 evident in the endometrium in
vivo when the uterus is infected postpartum with a wide
range of bacteria that posses lipopeptides. Secretion of
IL-8 attracts neutrophils from the peripheral circulation,
whereas IL-6 has multiple roles including activation of
neutrophils and simulationof the acute-phase response (5,
6, 38).Attraction of neutrophils by IL-8 is thought to form
the pus found in the uterus of affected animals, and IL-6
Figure 8. Ovarian steroids and endometrial cell responses to
lipopeptides. Endometrial epithelial (A) or stromal cells (B) were treated
for 24 hours in medium containing vehicle (V), estradiol (E, 3 pg/mL),
progesterone (P, 5 ng/nl), estradiol and progesterone (E 	 P), or
dexamethasone (D) and then were cultured with the same treatment
for a further 24 hours in control medium or medium containing 100
ng/mL PAM or 100 ng/mL FSL-1. Supernatants were harvested to
measure the accumulation of IL-6 by ELISA, and data are presented as
mean 	 SEM pg/mL and represent 3 independent experiments. Values
differ from those for vehicle, within treatment, when data were
analyzed by ANOVA using the Dunnett pairwise multiple comparison t
test: *, P  .05.
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induces the acute-phase response, which is evident in an-
imals with postpartum metritis (1, 4). Postpartum endo-
metritis is often caused by Gram-negative bacteria, and
endometrial cells detect and respond to LPS (18). How-
ever, E. coli are not always isolated from the postpartum
uterus, and Gram-positive bacteria also cause uterine dis-
ease (4). The ability of endometrial cells to detect and
respond to bacterial lipopeptides via TLR2/TLR1 and
TLR2/TLR6 is probably important for the onset and per-
sistence of endometritis in cattle.
Triacylated lipopeptides are bound by the extracellular
domain of TLR2/TLR1 heterodimers, whereas TLR2 in
concert with TLR6 binds diacylated bacterial lipopep-
tides, at least in mice and humans (10, 11, 39). These
germline-encoded, transmembrane receptors on the sur-
face of cells have an extracellular leucine-rich repeat do-
main typical of most TLRs (5, 6, 10). Crystallization of
TLR2/TLR1 and PAM reveals that 2 ester-bound acyl
chains of the lipopeptide interact with a hydrophobic
pocketwithin TLR2,whereas the amide-bound acyl chain
is inserted into a narrow channel inTLR1 (10).Diacylated
lipopeptides interact with the lipid-binding pocket of
mouse TLR2 in the same way as PAM, but TLR6 seems
unlikely to contain a lipid-binding channel, and so the
head group of lipopeptides may play a more important
during recognition by TLR2/TLR6 heterodimers. In the
present study, siRNAwas used to target eachTLR, and, as
expected from work on mice and human immune cells,
TLR2 was important for the endometrial cellular re-
sponses to PAM and FSL-1, whereas TLR1 was also in-
volved in the response to PAM. Surprisingly, the cellular
responses to FSL-1 involved not only TLR6 but also
TLR1. However, the present data are in agreement with a
recent report that human embryonic kidney cells stably
transfected with bovine TLR2 and TLR1 recognized di-
acylated and triacylated lipopeptides, which stimulated
the production of IL-8 (40). The difference between spe-
cies probably reflects the diversity of TLRs between cattle
and mice or humans (41). However, the concept of vari-
ation in ligand specificity is not unique to B. taurus be-
cause chicken TLR2/TLR1 heterodimers also recognize
FSL-1 (41). Of course, the TLRs have been under evolu-
tionary selection pressure since the origin of innate im-
mune receptors in lower organisms.WhenTLR structures
are compared across species, themost divergent part is the
extracellular domain involved in ligand binding, whereas
the regions involved in heterodimerization and intracel-
lular signaling are conserved. It is thought that the differ-
ences in ligand specificity between species are the result of
selective pressures for host-specific pathogens, and the less
discriminatory sensing by TLR1may reflect the microbial
environment cattle have encountered during evolution
(41).
To provide further evidence of the functional role of
TLR2 in endometrial cells, the phosphorylation of
MAPKs and NFB was examined (12). Indeed, there was
evidence of increased phosphorylation of p38, ERK2, and
p65 NFB in response to the lipopeptides, although there
was cell-specific variation. These observations are in ac-
cord with similar intracellular signaling responses in mu-
rine and human cells. In addition, inhibitors of p38 and
ERK1/2 activity reduced the accumulation of IL-6 in re-
sponse to PAM or FSL-1, without significantly affecting
epithelial or stromal cell survival.
Steroids regulate endometrial function during ovarian
cycles and pregnancy, and progesterone is thought to
dampen the immune response, whereas estrogens are pro-
tective against infections (42). Therefore, the lack of effect
of steroids on innate immunity in the present study was
surprising, particularly because dexamethasone was ef-
fective for reducing IL-6 responses to lipopeptides in the
epithelial cells. The TLRs are part of an ancient system for
protection against microbes and evolved in animals well
before viviparity (7). Furthermore, suppression of innate
immunitywould expose animals to the risk of overwhelm-
ing infection (43). Thus, on reflection, steroidsmight have
coevolved with adaptive immunity to modulate inflam-
mation, but innate immunitymay be fundamental for sur-
vival of animals.
In the present study, the concentrations of TNF and
IL-1were below the limits of detection of the assay, even
for cells treated for 24 hours with either PAMP. The lack
of protein accumulation probably reflects the rather brief
increase in TNF mRNA expression, even when endome-
trial cells are treatedwithLPS (44). Indeed, the association
between TNF mRNA expression and disease is inconsis-
tent in endometrial biopsies (15, 45). The lack of IL-1
protein was not surprising because secretion of mature
IL-1 is dependent on caspase-1 cleavage of pro-IL-1
after formation of the intracellular inflammasome com-
plex,which requires a second stimulus such as cell damage
aswell as thepresenceof PAMPs (46). In thepresent study,
there was no evidence of an effect of the PAMPs on en-
dometrial cell survival, although in some cell lines bacte-
rial lipopeptides are associated with increased apoptosis
(12). Because the endometrium is undergoing consider-
able remodeling during estrous cycles or the postpartum
period, future studies could explorewhetherPAMPsaffect
cell survival and extracellular matrix remodeling.
In conclusion, endometrial epithelial and stromal cells
mounted cellular responses to bacterial lipopeptides typ-
ical of innate immunitywith the accumulation of IL-6 and
IL-8. The cellular responses to the lipopeptides involved
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TLR2 in concert with TLR1 and TLR6 and with more
plasticity in the TLR-dependent recognition of FSL-1 for
bovine cells than anticipated from work with mice or hu-
mans. The bacterial lipopeptides activated MAPK and
NFB intracellular signaling pathways in endometrial
cells, and inhibitors targeting ERK1/2 or p38 limited the
inflammatory responses. Bacterial lipopeptides are impor-
tant for innate immunity because they are produced by all
bacteria, and thus TLR2 has generalized roles in detecting
bacteria, usually involving monocytic immune cells (12).
The findings in the present study that endometrial epithe-
lial and stromal cells sense and respond to bacterial lipo-
peptides now provide a mechanistic explanation linking
endometritis with infections by Gram-positive as well as
Gram-negative bacteria.
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